1. Home
  2. AFYA vs BCRX Comparison

AFYA vs BCRX Comparison

Compare AFYA & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AFYA
  • BCRX
  • Stock Information
  • Founded
  • AFYA 1999
  • BCRX 1986
  • Country
  • AFYA Brazil
  • BCRX United States
  • Employees
  • AFYA N/A
  • BCRX N/A
  • Industry
  • AFYA Other Consumer Services
  • BCRX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • AFYA Real Estate
  • BCRX Health Care
  • Exchange
  • AFYA Nasdaq
  • BCRX Nasdaq
  • Market Cap
  • AFYA 1.4B
  • BCRX 1.5B
  • IPO Year
  • AFYA 2019
  • BCRX 1994
  • Fundamental
  • Price
  • AFYA $15.66
  • BCRX $7.61
  • Analyst Decision
  • AFYA Hold
  • BCRX Buy
  • Analyst Count
  • AFYA 5
  • BCRX 6
  • Target Price
  • AFYA $19.60
  • BCRX $15.17
  • AVG Volume (30 Days)
  • AFYA 87.6K
  • BCRX 2.2M
  • Earning Date
  • AFYA 03-13-2025
  • BCRX 02-24-2025
  • Dividend Yield
  • AFYA N/A
  • BCRX N/A
  • EPS Growth
  • AFYA 62.61
  • BCRX N/A
  • EPS
  • AFYA 1.17
  • BCRX N/A
  • Revenue
  • AFYA $584,951,886.00
  • BCRX $412,579,000.00
  • Revenue This Year
  • AFYA $16.90
  • BCRX $38.44
  • Revenue Next Year
  • AFYA $11.78
  • BCRX $21.23
  • P/E Ratio
  • AFYA $13.45
  • BCRX N/A
  • Revenue Growth
  • AFYA 16.67
  • BCRX 29.92
  • 52 Week Low
  • AFYA $14.52
  • BCRX $4.03
  • 52 Week High
  • AFYA $22.24
  • BCRX $8.88
  • Technical
  • Relative Strength Index (RSI)
  • AFYA 51.39
  • BCRX 50.40
  • Support Level
  • AFYA $14.80
  • BCRX $6.96
  • Resistance Level
  • AFYA $15.95
  • BCRX $8.02
  • Average True Range (ATR)
  • AFYA 0.39
  • BCRX 0.45
  • MACD
  • AFYA 0.09
  • BCRX -0.04
  • Stochastic Oscillator
  • AFYA 65.65
  • BCRX 42.48

About AFYA Afya Limited

Afya Ltd is a medical education group based in Brazil. Its education portfolio has several courses in addition to Medicine, such as Management, Dentistry, Law, Engineering, Nursing, Psychology, and Accounting Sciences, among others. It has three segments; Undergrad provides educational services through undergraduate courses related to medicine, other health sciences, and other undergraduate programs, Continuing Education provides specialization programs and graduate courses in medicine; and Digital Services provides content and technology for medical education, clinical decisions software, practice management tools (that encompass electronic medical records, telemedicine, and digital prescription, and provides access, demand and efficiency for the healthcare players.

About BCRX BioCryst Pharmaceuticals Inc.

BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.

Share on Social Networks: